Clinical Trial Update: Irinotecan Plus Lobaplatin Versus Irinotecan in the Second-line Treatment of Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing irinotecan plus lobaplatin vs irinotecan in second-line treatment of small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Irinotecan (Irinotecan)
• Lobaplatin (lobaplatin)

Snippet

Sponsor: ShengFa Su | Conditions: Small-cell Lung Cancer | Phase 2 | Status: UNKNOWN